Find clinical trials for Regeneron Pharmaceuticals. Search for Regeneron Pharmaceuticals clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 61
A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
for
Healthy Volunteers,
Location: Miami FL, Marrero LA, Houston TX, Los Angeles CA
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT05648214
Phase 1, Phase 2, Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
for
Atrial Fibrillation (AF)
Location: Staten Island NY, Ft. Washington MD, Vienna VA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07626411
Phase 3, Recruiting
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
for
Overweight or Obesity
Location: Waterbury CT, New York NY, Rochester NY, Doral FL,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07685808
Phase 2, Recruiting
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
for
Symptomatic Venous Thromboembolism (VTE)
Location: Boston MA, New York NY, Teaneck NJ, Annapolis MD,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07213778
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Fel d 1 Monoclonal Antibodies in Adult and Pediatric Participants With Allergic Conjunctivitis Due to Cat Allergy
for
Allergic Conjunctivitis
Location: Andover MA
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 8+
Code: NCT07675811
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Bethesda MD, St. Petersburg FL, Baton Rouge LA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07609940
Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Tampa FL, Zion IL, St Louis MO, Houston TX, Goodyear AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07594106
Phase 1, Phase 2, Recruiting
A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
for
Paroxysmal Nocturnal Hemoglobinuria
Location: Levis
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154745
Phase 3, Recruiting
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
for
Venous Thromboembolism (VTE)
Location: New York NY
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07493304
Phase 3, Recruiting
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
for
Diffuse Large B-cell Lymphoma (DLBCL)
Location: Boston MA, Stony Brook NY, New Brunswick NJ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091865
Phase 3, Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
for
Atrial Fibrillation (AF)
Location: Staten Island NY, Vienna VA, Medley FL, Concord NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07430956
Phase 3, Recruiting
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Newark DE, Baltimore MD, Washington D.C. DC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase 2, Recruiting
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
for
Generalized Lipodystrophy
Location: Ann Arbor MI, Dallas TX
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 2+
Code: NCT07220785
Phase 3, Recruiting
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
for
Parkinsons Disease
Location: Montreal, Ottawa
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT07216066
Phase 1, Recruiting
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Willow Grove PA, Richmond VA, Fairfax VA, Rochester NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
for
Follicular Lymphoma (FL)
Location: Saint John, Boston MA, Quebec, Stony Brook NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06091254
Phase 3, Recruiting
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
for
Functional Hypothalamic Amenorrhea, FHA
Location: New Haven CT, Norfolk VA, Hershey PA,
Sponsor: Regeneron Pharmaceuticals
Sex: Female
Age: 18 - 40
Code: NCT07235917
Phase 2, Recruiting
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
for
Diabetic Kidney Disease (DKD)
Location: New Haven CT, The Bronx NY, Bethlehem PA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07271186
Phase 2, Recruiting
Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
for
Geographic Atrophy (GA)
Location: East Weymouth MA, The Woodlands TX, Dallas TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50+
Code: NCT07230834
Phase 1, Recruiting
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor